GRIN1 and acrodermatitis enteropathica: To test this idea, the authors carried out a rigorous, multilevel analysis of cellular, network, and behavioral parameters in mice following unilateral intraventricular administration of an anti-GluN1 monoclonal antibody (mAb3[GluN1]) derived from a patient with NMDAR-AE.